Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Chemotherapy or chemotherapy + hormonotherapy in women over 70 with HER2 receptor-negative but estrogen receptor-positive breast cancer acco… Ended

2024-516996-34-00 oestrogen-receptor (ER)-positive HER2-negative breast c 5 2012-04-12
Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients Ended

2024-515171-35-00 Prostatic adenocarnicoma with high risk of recurrence 5 2011-07-06
Treatment protocol for osteosarcomas in children, adolescents and adults including a randomized trial and biological studies Ended

2024-514756-32-00 High grade osteosarcoma 5 2007-03-19
An Open-label Study to check Safety, Tolerability and medication behaviour of a capsule with AZD6244 in Patients with Advanced Solid Maligna… Ended

2022-500685-10-00 Advanced solid malignancies 3 2007-02-28
Phase 1b Study of Tarlatamab in Combination with YL201 with or without Anti-PD-L1 in Subjects with Extensive Stage Small Cell Lung Cancer (D… Halted

2024-515903-21-00 Extensive Stage Small Cell Lung Cancer (ES-SCLC) 3 2025-10-31
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors Halted

2024-512927-36-00 Advanced or Metastatic Urothelial Carcinoma or Other So 1 2025-10-30
A study of AZD2962, an IRAK4 inhibitor, in Participants with Haematologic Neoplasms Halted

2025-520786-44-00 Myelodysplastic syndromes 7 2025-10-21
IMMUNORARE5 : A national platform of 5 academic phase II trials coordinated by Lyon university hospital to assess the safety and the efficac… Halted

2024-517254-99-00 The patients enrolled in IMMUNORARE will be adult patie 4 2025-09-16
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors Halted

2024-516916-93-00 This study will be a Phase 1b, global, multicenter, ope 3 2025-09-08
A study to test different doses of BI 765049 in people with advanced cancer of the colon, rectum, stomach, or pancreas Halted

2024-519301-36-00 colorectal carcinoma (CRC) 3 2025-07-11
CEB-01 in paediatrics with locally resectable abdominal tumours. Halted

2024-520054-38-00 Desmoplastic small round cell tumour 4 2025-05-06
NeoART – A phase Ib/II platform trial evaluating the safety and activity of neoadjuvant trastuzumab-deruxtecan containing combination therap… Halted

2024-518841-12-00 HER2 positive resectable esophagogastric adenocarcinoma 9 2025-03-25
A Phase 1, Open-Label, Multicenter Study of INCB161734 in Participants With Advanced or Metastatic Solid Tumors with KRAS G12D Mutation Halted

2023-507091-47-00 Advanced or metastatic solid tumors 1 2025-02-10
Neoadjuvant electrochemotherapy for colorectal cancer - a phase 2 trial Halted

2025-520755-91-00 Colorectal cancer 4 2025-01-31
A clinical research study comparing two cisplatin dosing schedules combined with radiation for patients with advanced head and neck cancer. Halted

2024-515237-15-00 Advanced head and neck cancer 10 2025-01-21
PHASE IB/II STUDY TO EVALUATE SAFETY AND EFFICACY OF DEBIO 0123 AND SACITUZUMAB GOVITECAN IN TNBC OR HR+/HER2- ADVANCED/ METASTATIC BREAST C… Halted

2024-516322-60-00 TRIPLE-NEGATIVE OR HR+/HER2– ADVANCED/METASTATIC BREAST 9 2025-01-17
Study of Taxane-Platinum followed by a maintenance with avelumab and cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma… Halted

2023-510559-41-00 Recurrent or Metastatic Squamous Cell Carcinoma of the 4 2025-01-02
A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patient… Halted

2024-510987-22-00 Advanced High-Grade Osteosarcoma 4 2024-12-30
Preoperative immunotherapy with atezolizumab (Tecentriq®) and tiragolumab or atezolizumab (Tecentriq®) and bevacizumab (Avastin®) in patient… Halted

2022-503044-40-00 Colorectal liver metastases (CRLM) 4 2024-12-16
TryptoBPH - Proof-of-concept study to evaluate the safety and efficacy of tryptophan in patients with BPH Halted

2024-519076-75-00 Benign prostatic hyperplasia 4 2024-12-05
A Phase 1b Study of Neoadjuvant Xaluritamig in Subjects With Newly Diagnosed Localized Intermediate or High-Risk Prostate Cancer Halted

2024-511965-13-00 Newly diagnosed localized Intermediate or High‐Risk Pro 3 2024-11-25
PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy f… Halted

2023-506194-35-00 Colorectal liver metastases 5 2024-11-21
Phase II Open-Label, Single Arm, Multicenter Study of Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma Halted

2023-510560-12-00 High-risk smoldering multiple myeloma 4 2024-10-03
A study to evaluate novel immunotherapy combinations in participants with advanced non-small cell lung cancer (NSCLC) Halted

2023-508730-34-00 Non-small cell lung cancer (NSCLC): - Locally advanced 9 2024-07-10